Literature DB >> 12183146

Use of 2% 2-phenoxyethanol and 0.1% octenidine as antiseptic in premature newborn infants of 23-26 weeks gestation.

C Bührer1, S Bahr, J Siebert, R Wettstein, C Geffers, M Obladen.   

Abstract

In preterm newborn infants, topical iodine-containing antiseptics disturb thyroid hormone regulation while alcohol-based disinfectants may cause local burns. We therefore investigated the use of an aqueous solution containing 0.1% octenidine and 2% 2-phenoxyethanol for skin disinfection during the first seven days of life in premature newborns with a gestational age <27 weeks who were consecutively admitted to our level III neonatal intensive care unit between November 1, 2000 and December 31, 2001 (N=24). In boys. (N=13) the renal excretion of absorbed 2-phenoxyethanol and its metabolite 2-phenoxyacetic acid was quantitated by high-pressure liquid chromatography. In the most immature newborn (gestational age 23 6/7 weeks), a transient erythematous reaction was observed following application of the octenidine/phenoxyethanol solution prior to umbilical vessel catheterization. No other local reactions were observed. The urinary concentration of 2-phenoxyethanol was <2 ppm in all samples, while urinary 2-phenoxyacetic acid concentrations reached 5-95 ppm (median 24 ppm). One infant had a culture-proven septicaemia (Bacillus species) during the first seven days of life. We conclude that, in contrast to alcohol-based antiseptics, an aqueous solution of 0.1% octenidine and 2-phenoxyethanol does not cause major skin damage in premature newborn infants <27 weeks' gestation. 2-Phenoxyethanol is readily absorbed by the newborn's skin but apparently undergoes extensive oxidative metabolization to 2-phenoxyacetic acid.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12183146     DOI: 10.1053/jhin.2002.1249

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  7 in total

Review 1.  Safety of anti-infective agents for skin preparation in premature infants.

Authors:  S Upadhyayula; M Kambalapalli; C J Harrison
Journal:  Arch Dis Child       Date:  2007-07       Impact factor: 3.791

Review 2.  Antiseptic use in the neonatal intensive care unit - a dilemma in clinical practice: An evidence based review.

Authors:  Sundar Sathiyamurthy; Jayanta Banerjee; Sunit V Godambe
Journal:  World J Clin Pediatr       Date:  2016-05-08

3.  The effect of a combination of 0.1% octenidine dihydrochloride and 2% 2-phenoxyethanol (octenisept) on wound healing in pigs in vivo and its in vitro percutaneous permeation through intact and barrier disrupted porcine skin.

Authors:  Jessica Stahl; Michael Braun; Joerg Siebert; Manfred Kietzmann
Journal:  Int Wound J       Date:  2010-02       Impact factor: 3.315

4.  The percutaneous permeation of a combination of 0.1% octenidine dihydrochloride and 2% 2-phenoxyethanol (octenisept®) through skin of different species in vitro.

Authors:  Jessica Stahl; Michael Braun; Joerg Siebert; Manfred Kietzmann
Journal:  BMC Vet Res       Date:  2011-08-11       Impact factor: 2.741

5.  Preterm Birth Affects the Risk of Developing Immune-Mediated Diseases.

Authors:  Sybelle Goedicke-Fritz; Christoph Härtel; Gabriela Krasteva-Christ; Matthias V Kopp; Sascha Meyer; Michael Zemlin
Journal:  Front Immunol       Date:  2017-10-09       Impact factor: 7.561

6.  Leakage of fluid around endotracheal tube cuffs: a cadaver study.

Authors:  Falk Birkenfeld; Ralph Lucius; Kristian Ewald
Journal:  Korean J Anesthesiol       Date:  2013-11-29

Review 7.  Wound Antiseptics and European Guidelines for Antiseptic Application in Wound Treatment.

Authors:  Zuzanna Łucja Babalska; Marzena Korbecka-Paczkowska; Tomasz M Karpiński
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.